Cargando…

HPV types and cofactors causing cervical cancer in Peru

We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women. Information on risk factors was obtained by personal interview. Using PCR-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, C, Muñoz, N, Klug, S, Almonte, M, Guerrero, I, Alvarez, M, Velarde, C, Galdos, O, Castillo, M, Walboomers, J, Meijer, C, Caceres, E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375092/ https://www.ncbi.nlm.nih.gov/pubmed/11592767 http://dx.doi.org/10.1054/bjoc.2001.1948

Ejemplares similares

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears
por: Jacobs, M V, et al.
Publicado: (2000)

Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao
por: Hooi, Desiree J., et al.
Publicado: (2018)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
por: Nobbenhuis, M A E, et al.
Publicado: (2001)

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
por: van Ballegooijen, M., et al.
Publicado: (1997)

A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
por: Jacobs, M V, et al.
Publicado: (1999)

Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru
por: Almonte, Maribel, et al.
Publicado: (2015)

Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
por: de Gruijl, T D, et al.
Publicado: (1999)

Human papillomavirus and invasive cervical cancer in Brazil.
por: Eluf-Neto, J., et al.
Publicado: (1994)

Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas
por: Cruz, I, et al.
Publicado: (1999)

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993)

HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study
por: Berraho, Mohamed, et al.
Publicado: (2017)

Cervical cancer screening by visual inspection and HPV testing in Eswatini
por: Ginindza, Themba G., et al.
Publicado: (2022)

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
por: Kitchener, H C, et al.
Publicado: (2006)

Barriers to the uptake of cervical cancer services and attitudes towards adopting new interventions in Peru
por: Vasudevan, Lavanya, et al.
Publicado: (2020)

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
por: Hildesheim, A, et al.
Publicado: (2001)

Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7
por: Kamradt, M C, et al.
Publicado: (2000)

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort
por: Deacon, J M, et al.
Publicado: (2000)

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial
por: Sargent, A, et al.
Publicado: (2008)

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
por: Cuzick, J, et al.
Publicado: (2000)

Expression of membrane cofactor protein (MCP, CD46) in human liver diseases
por: Kinugasa, N, et al.
Publicado: (1999)

Testing positive for Human Papillomavirus (HPV) at primary HPV cervical screening: A qualitative exploration of women’s information needs and preferences for communication of results
por: Mulcahy Symmons, Sophie, et al.
Publicado: (2021)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions
por: Andersson, S, et al.
Publicado: (2000)

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
por: Muñoz, N, et al.
Publicado: (2009)

High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program
por: Torres-Poveda, K., et al.
Publicado: (2019)

Knowledge, attitudes, and practices associated with frequent influenza vaccination among healthcare personnel in Peru, 2016─2018
por: Sumner, Kelsey M., et al.
Publicado: (2023)

HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients
por: Hu, X, et al.
Publicado: (2001)

Farmers’ perceptions and acceptance of crossbred guinea pigs in Mantaro Valley, Peru
por: Cedano-Castro, J. I., et al.
Publicado: (2023)

Parental Acceptance of HPV Vaccine in Peru: A Decision Framework
por: Bartolini, Rosario M., et al.
Publicado: (2012)

Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes
por: Arians, Nathalie, et al.
Publicado: (2019)

Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden – A population based cohort study
por: Bergengren, Lovisa, et al.
Publicado: (2021)

Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening
por: Catarino, Rosa, et al.
Publicado: (2022)

Development and validation of the cervical cancer knowledge scale and HPV testing knowledge scale in a sample of Canadian women
por: Haward, Ben, et al.
Publicado: (2022)

Women’s perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru: a qualitative study
por: Morse, Rachel M., et al.
Publicado: (2022)

Identifying HPV vaccine narrative communication needs among parents on social media
por: Massey, Philip M., et al.
Publicado: (2021)

HPV infection in women with and without cervical cancer in Conakry, Guinea
por: Keita, N, et al.
Publicado: (2009)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Young Danish HPV vaccinated women’s knowledge, barriers and facilitators towards cervical cancer screening: A qualitative study
por: Mortensen, Julie Hedegaard, et al.
Publicado: (2021)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vmcfc62u3632gefbte1h7a7o6s